» Authors » Natasa Przulj

Natasa Przulj

Explore the profile of Natasa Przulj including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 82
Citations 2834
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Przulj N, Malod-Dognin N
Bioinform Adv . 2025 Feb; 5(1):vbae164. PMID: 39927291
Motivation: Heterogeneous, interconnected, systems-level, molecular (multi-omic) data have become increasingly available and key in precision medicine. We need to utilize them to better stratify patients into risk groups, discover new...
2.
Sokolina K, Kittanakom S, Snider J, Kotlyar M, Maurice P, Gandia J, et al.
Mol Syst Biol . 2025 Jan; 21(2):208-209. PMID: 39762653
No abstract available.
3.
Windels S, Tello Velasco D, Rotkevich M, Malod-Dognin N, Przulj N
Bioinformatics . 2024 Nov; 40(11). PMID: 39495120
Motivation: Spatial Analysis of Functional Enrichment (SAFE) is a popular tool for biologists to investigate the functional organization of biological networks via highly intuitive 2D functional maps. To create these...
4.
Zitnik M, Li M, Wells A, Glass K, Morselli Gysi D, Krishnan A, et al.
Bioinform Adv . 2024 Aug; 4(1):vbae099. PMID: 39143982
Summary: Network biology is an interdisciplinary field bridging computational and biological sciences that has proved pivotal in advancing the understanding of cellular functions and diseases across biological systems and scales....
5.
Doria-Belenguer S, Xenos A, Ceddia G, Malod-Dognin N, Przulj N
Bioinform Adv . 2024 Jun; 4(1):vbae075. PMID: 38827411
Summary: Common approaches for deciphering biological networks involve network embedding algorithms. These approaches strictly focus on clustering the genes' embedding vectors and interpreting such clusters to reveal the hidden information...
6.
Maier A, Hartung M, Abovsky M, Adamowicz K, Bader G, Baier S, et al.
Nucleic Acids Res . 2024 May; 52(W1):W481-W488. PMID: 38783119
In recent decades, the development of new drugs has become increasingly expensive and inefficient, and the molecular mechanisms of most pharmaceuticals remain poorly understood. In response, computational systems and network...
7.
Mihajlovic K, Ceddia G, Malod-Dognin N, Novak G, Kyriakis D, Skupin A, et al.
Sci Rep . 2024 May; 14(1):10983. PMID: 38744869
Parkinson's disease (PD) is a complex neurodegenerative disorder without a cure. The onset of PD symptoms corresponds to 50% loss of midbrain dopaminergic (mDA) neurons, limiting early-stage understanding of PD....
8.
Gureghian V, Herbst H, Kozar I, Mihajlovic K, Malod-Dognin N, Ceddia G, et al.
Cancer Gene Ther . 2023 Jul; 30(10):1330-1345. PMID: 37420093
Therapy Induced Senescence (TIS) leads to sustained growth arrest of cancer cells. The associated cytostasis has been shown to be reversible and cells escaping senescence further enhance the aggressiveness of...
9.
Maier A, Hartung M, Abovsky M, Adamowicz K, Bader G, Baier S, et al.
ArXiv . 2023 Jun; PMID: 37332567
In recent decades, the development of new drugs has become increasingly expensive and inefficient, and the molecular mechanisms of most pharmaceuticals remain poorly understood. In response, computational systems and network...
10.
Malod-Dognin N, Ceddia G, Gvozdenov M, Tomic B, Dunjic Manevski S, Djordjevic V, et al.
PLoS One . 2023 Apr; 18(4):e0284084. PMID: 37098010
Antithrombin resistance is a rare subtype of hereditary thrombophilia caused by prothrombin gene variants, leading to thrombotic disorders. Recently, the Prothrombin Belgrade variant has been reported as a specific variant...